calcium acetate has been researched along with Kidney Diseases in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (8.33) | 18.2507 |
| 2000's | 7 (58.33) | 29.6817 |
| 2010's | 4 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fitchett, D; Jamal, SA; Lok, CE; Mendelssohn, DC; Tsuyuki, RT | 1 |
| Cancela, AL; Canziani, ME; Carvalho, AB; Cuppari, L; Dos Reis, LM; Draibe, SA; Graciolli, FG; Jorgetti, V; Moysés, RM; Oliveira, RB | 1 |
| Bagga, A; Bose, T; Gulati, A; Hari, P; Sridhar, V | 1 |
| Caglar, K; Eyileten, T; Kilic, S; Mallamaci, F; Oguz, Y; Saglam, M; Sonmez, A; Vural, A; Yaman, H; Yenicesu, M; Yilmaz, MI; Zoccali, C | 1 |
| Jaber, BL; Susantitaphong, P | 1 |
| Binswanger, U; Hess, B | 1 |
| Martin, CJ; Reams, SM | 1 |
| Goudas, PC | 1 |
| Bonzel, KE; Dittrich, K; Düker, G; Fründ, S; Haffner, D; Hoppe, B; John, U; Klaus, G; Offner, G; Pieper, AK; Querfeld, U; Stübinger, A | 1 |
| Drüeke, TB; Landais, P | 1 |
| Blair, AT; Burke, SK; Cangiano, JL; Chasan-Taber, S; Dillon, MA; Fischer, D; Garrett, L; Ling, BN; Reed, J; Suki, WN; Zabaneh, R | 1 |
| Barreto, DV; Barreto, FC; Canziani, ME; Carvalho, AB; Draibe, SA; Jorgetti, V; Moysés, RM; Neves, KR | 1 |
1 review(s) available for calcium acetate and Kidney Diseases
| Article | Year |
|---|---|
The effects of calcium-based versus non-calcium-based phosphate binders on mortality among patients with chronic kidney disease: a meta-analysis.
Topics: Acetates; Calcium Carbonate; Calcium Compounds; Cause of Death; Chelating Agents; Chronic Disease; Humans; Kidney Diseases; Lanthanum; Polyamines; Sevelamer | 2009 |
6 trial(s) available for calcium acetate and Kidney Diseases
| Article | Year |
|---|---|
Early control of PTH and FGF23 in normophosphatemic CKD patients: a new target in CKD-MBD therapy?
Topics: Acetates; Adult; Biomarkers; Bone Diseases, Metabolic; Calcium Compounds; Chelating Agents; Chronic Disease; Female; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Humans; Hyperparathyroidism, Secondary; Kidney Diseases; Male; Middle Aged; Parathyroid Hormone; Phosphates; Pilot Projects; Polyamines; Sevelamer; Time Factors; Treatment Outcome | 2010 |
Short-term efficacy of sevelamer versus calcium acetate in patients with chronic kidney disease stage 3-4.
Topics: Acetates; Calcium Compounds; Chelating Agents; Child; Child, Preschool; Chronic Disease; Female; Humans; Kidney Diseases; Male; Polyamines; Sevelamer; Severity of Illness Index; Time Factors | 2010 |
Comparison of calcium acetate and sevelamer on vascular function and fibroblast growth factor 23 in CKD patients: a randomized clinical trial.
Topics: Acetates; Adult; Calcium Compounds; Chelating Agents; Chronic Disease; Comorbidity; Endothelium, Vascular; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Forearm; Humans; Hyperphosphatemia; Kidney Diseases; Middle Aged; Phosphates; Polyamines; Prospective Studies; Regional Blood Flow; Sevelamer; Severity of Illness Index; Treatment Outcome; Vasodilation | 2012 |
A randomized crossover trial comparing sevelamer with calcium acetate in children with CKD.
Topics: Acetates; Adolescent; Calcium Compounds; Child; Child, Preschool; Chronic Disease; Cross-Over Studies; Female; Humans; Infant; Kidney Diseases; Male; Polyamines; Sevelamer | 2006 |
Effects of sevelamer and calcium-based phosphate binders on mortality in hemodialysis patients.
Topics: Acetates; Adult; Age Factors; Aged; Calcium; Calcium Carbonate; Calcium Compounds; Cardiovascular Diseases; Chelating Agents; Chronic Disease; Female; Humans; Kidney Diseases; Male; Middle Aged; Phosphorus; Polyamines; Renal Dialysis; Sevelamer; Treatment Outcome | 2007 |
K/DOQI-recommended intact PTH levels do not prevent low-turnover bone disease in hemodialysis patients.
Topics: Acetates; Adult; Biopsy; Bone Remodeling; Brazil; Calcium Compounds; Chelating Agents; Chronic Disease; Chronic Kidney Disease-Mineral and Bone Disorder; Female; Humans; Kidney Diseases; Male; Middle Aged; Parathyroid Hormone; Polyamines; Practice Guidelines as Topic; Prospective Studies; Reference Values; Renal Dialysis; Sevelamer | 2008 |
5 other study(ies) available for calcium acetate and Kidney Diseases
| Article | Year |
|---|---|
Potential interaction between sevelamer and fat-soluble vitamins: a hypothesis.
Topics: Acetates; Calcium Compounds; Dietary Supplements; Endothelium, Vascular; Female; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Forearm; Humans; Kidney Diseases; Male; Polyamines; Regional Blood Flow; Renal Dialysis; Sevelamer; Vitamin K 2; Vitamin K Deficiency | 2012 |
Long-term administration of calcium acetate efficiently controls severe hyperphosphataemia in haemodialysis patients.
Topics: Acetates; Adult; Calcium; Calcium Compounds; Female; Humans; Hypercalcemia; Hyperphosphatemia; Kidney Diseases; Male; Middle Aged; Phosphates; Renal Dialysis; Young Adult | 1990 |
The renal dietitian's role in managing hyperphosphatemia and secondary hyperparathyroidism in dialysis patients: a national survey.
Topics: Acetates; Bone and Bones; Calcium Carbonate; Calcium Compounds; Dietetics; Epoxy Compounds; Ergocalciferols; Humans; Hyperparathyroidism, Secondary; Kidney Diseases; Phosphates; Phosphorus, Dietary; Polyamines; Polyethylenes; Renal Dialysis; Sevelamer; Surveys and Questionnaires; Vitamin D | 2003 |
Renal disease medications and evidence-biased medicine.
Topics: Acetates; Calcium Carbonate; Calcium Compounds; Evidence-Based Medicine; Humans; Kidney Diseases | 2003 |
Paricalcitol for treatment of secondary hyperparathyroidism in CKD patients.
Topics: Acetates; Calcitriol; Calcium; Calcium Compounds; Chronic Disease; Cinacalcet; Clinical Trials, Phase III as Topic; Ergocalciferols; Humans; Hyperparathyroidism, Secondary; Kidney Diseases; Naphthalenes; Parathyroid Hormone; Phosphorus; Randomized Controlled Trials as Topic | 2006 |